← Back to Patent Explorer
US4334540A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of diagnosing periodontal disease through the detection of pyridine compounds

Assignee: Monell Chemical Senses Center
•
Filing: 1979-05-01
•
Granted: 1982-06-15
•
Expires: 1999-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel method of diagnosing periodontal disease is disclosed wherein telltale pyridine and alkyl-pyridine compounds which are detected in the oral cavity are indicative of periodontal disease. An alternate embodiment method is disclosed wherein increased concentrations of certain other compounds are detected to confirm the presence of periodontal disease.

Inventors

  • 👤 George Preti
  • 👤 James G. Kostelc
  • 👤 Philip R. Zelson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:00
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; Y; Y10; Y10T; Y10T436/00; Y10T436/14

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 89 words
A method of evaluating an individual to determine and diagnose the existence of periodontal disease in the oral cavity of that individual, comprising the steps of: (a) collecting a test substance from the oral cavity of the individual to be evaluated; and (b) presenting that test substance to an indicator means for selectively responding at least qualitatively to the presence of at least one indicative diagnostic pyridine compound in that test substance, whereby a qualitative response of said indicator means diagnoses the existence of periodontal disease in said individual.
Claim 2
Independent Claim 89 words
A method of evaluating an individual to determine and diagnose the existence of periodontal disease in the oral cavity of that individual, comprising the steps of: (a) collecting a test substance from the oral cavity of the individual to be evaluated; and (b) presenting that test substance to an indicator means for selectively responding at least qualitatively to the presence of at least one indicative diagnostic pyridine compound in that test substance, whereby a qualitative response of said indicator means diagnoses the existence of periodontal disease in said individual.
Claim 3
Dependent Claim 14 words
The method of claim 1 wherein step (a) comprises collecting saliva from that individual.
Claim 4
Dependent Claim 24 words
The method of claim 2 wherein step (a) comprises the steps of incubating said saliva and collecting air from the headspace adjacent said saliva.
Claim 5
Dependent Claim 20 words
The method of claim 1 wherein step (a) comprises collecting air from at least one gingival crevice of said individual.
Claim 6
Dependent Claim 15 words
The method of claim 1 wherein step (a) comprises collecting mouth air from said individual.
Claim 7
Dependent Claim 20 words
The method of claim 1 wherein step (b) comprises providing an indicator means for qualitatively responding to at least pyridine.
Claim 8
Dependent Claim 21 words
The method of claim 1 wherein step (b) comprises providing an indicator means for qualitatively responding to at least a picoline.
Claim 9
Dependent Claim 21 words
The method of claim 1 wherein step (b) comprises providing an indicator means for qualitatively responding to at least 2-methyl pyridine.
Claim 10
Dependent Claim 21 words
The method of claim 1 wherein step (b) comprises providing an indicator means for qualitatively responding to at least 3-methyl pyridine.
Claim 11
Dependent Claim 41 words
The method of claim 1 wherein said indicator means also responds quantitatively to at least a second indicative diagnostic compound to sense and indicate increased concentrations thereof, said increased concentrations being indicative of the existence of periodontal disease in said individual.
Claim 12
Dependent Claim 18 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate concentrations of p-cresol.
Claim 13
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of phenol.
Claim 14
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of dimethyltrisulfide.
Claim 15
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of dimethyldisulfide.
Claim 16
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of hexadecanol.
Claim 17
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of tetradecanol.
Claim 18
Dependent Claim 19 words
The method of claim 10 wherein said indicator means responds quantitatively to sense and indicate increased concentrations of dodecanol.

References Cited (Backward Citations)

US3986494A Cited
US4010738A Cited
US4119089A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-06-14 1985-12-14 1986-06-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-06-14 1989-12-14 1990-06-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-06-14 1993-12-14 1994-06-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag